Your browser is no longer supported. Please, upgrade your browser.
TherapeuticsMD, Inc.
Index- P/E- EPS (ttm)-0.71 Insider Own11.21% Shs Outstand272.56M Perf Week-9.87%
Market Cap538.36M Forward P/E- EPS next Y-0.33 Insider Trans0.00% Shs Float266.15M Perf Month-18.93%
Income-190.90M PEG- EPS next Q-0.10 Inst Own42.70% Short Float27.30% Perf Quarter3.01%
Sales58.20M P/S9.25 EPS this Y-21.30% Inst Trans2.30% Short Ratio5.34 Perf Half Y-4.86%
Book/sh-0.43 P/B- EPS next Y45.90% ROA-83.20% Target Price- Perf Year-23.89%
Cash/sh0.20 P/C6.76 EPS next 5Y17.60% ROE310.20% 52W Range0.85 - 2.75 Perf YTD13.22%
Dividend- P/FCF- EPS past 5Y-14.60% ROI-79.10% 52W High-50.18% Beta1.97
Dividend %- Quick Ratio2.40 Sales past 5Y27.00% Gross Margin77.20% 52W Low60.61% ATR0.21
Employees348 Current Ratio2.60 Sales Q/Q-18.60% Oper. Margin- RSI (14)38.51 Volatility13.44% 11.97%
OptionableYes Debt/Eq- EPS Q/Q9.70% Profit Margin- Rel Volume1.37 Prev Close1.30
ShortableYes LT Debt/Eq- EarningsMar 02 BMO Payout- Avg Volume13.62M Price1.37
Recom1.70 SMA20-22.50% SMA50-11.58% SMA200-6.81% Volume18,653,101 Change5.38%
Aug-07-20Downgrade Jefferies Hold → Underperform
May-19-20Downgrade JP Morgan Overweight → Neutral
Dec-02-19Initiated Guggenheim Buy
Oct-17-19Initiated H.C. Wainwright Buy $7
Apr-30-19Resumed Noble Capital Markets Outperform $13
Jun-15-18Initiated JP Morgan Overweight $11
Sep-08-17Initiated Morgan Stanley Equal-Weight $6
Jul-11-17Upgrade Oppenheimer Perform → Outperform
May-09-17Downgrade Oppenheimer Outperform → Perform
Nov-22-16Resumed Jefferies Buy $18
Nov-22-16Initiated Oppenheimer Outperform
Nov-07-16Resumed Guggenheim Buy
Apr-04-16Initiated Goldman Buy $10
Dec-08-15Reiterated Stifel Buy $10 → $14
Dec-08-15Reiterated Jefferies Buy $15 → $18
Sep-21-15Reiterated Jefferies Buy $7 → $15
Jun-09-15Initiated Guggenheim Buy
Jul-08-14Initiated FBR Capital Outperform $34
Apr-17-14Reiterated Noble Financial Buy $9 → $13
Jan-28-14Reiterated Noble Financial Buy $7.25 → $9
Mar-02-21 07:00PM  
Mar-01-21 10:05AM  
Feb-23-21 04:05PM  
Feb-18-21 10:16AM  
Feb-16-21 04:01PM  
Feb-11-21 09:02AM  
Feb-10-21 04:01PM  
Feb-03-21 12:50PM  
Jan-29-21 03:29AM  
Jan-12-21 08:34AM  
Dec-29-20 07:00AM  
Dec-17-20 03:47AM  
Dec-15-20 08:13AM  
Dec-11-20 10:34AM  
Nov-13-20 04:05PM  
Nov-11-20 12:29PM  
Nov-10-20 08:58AM  
Nov-09-20 04:01PM  
Nov-02-20 12:31PM  
Oct-29-20 07:00AM  
Oct-28-20 12:33PM  
Oct-26-20 04:05PM  
Oct-22-20 01:16PM  
Oct-09-20 08:00AM  
Oct-07-20 08:43AM  
Oct-06-20 10:03AM  
Oct-02-20 10:17AM  
Sep-25-20 09:02AM  
Sep-21-20 05:01PM  
Sep-16-20 01:54PM  
Sep-10-20 06:50AM  
Sep-09-20 04:05PM  
Aug-25-20 07:30AM  
Aug-14-20 10:34AM  
Aug-11-20 11:35AM  
Aug-06-20 09:45AM  
Jul-30-20 12:34PM  
Jul-29-20 06:50AM  
Jul-28-20 12:33PM  
Jul-15-20 06:50AM  
Jun-28-20 09:41AM  
Jun-25-20 04:49PM  
Jun-01-20 06:50AM  
May-27-20 09:47AM  
May-25-20 09:36PM  
May-08-20 06:50AM  
May-07-20 12:00AM  
May-06-20 09:35AM  
Apr-29-20 03:00PM  
Apr-28-20 06:50AM  
Apr-27-20 12:32PM  
Apr-22-20 06:50AM  
Mar-27-20 08:02AM  
Mar-26-20 04:05PM  
Mar-24-20 07:45AM  
Mar-16-20 06:00AM  
Mar-12-20 11:21AM  
Mar-11-20 06:25PM  
Mar-03-20 12:56PM  
Feb-24-20 08:30AM  
Feb-20-20 08:15AM  
Feb-13-20 12:31PM  
Feb-10-20 06:30AM  
Feb-03-20 06:30AM  
Jan-15-20 10:37AM  
Jan-07-20 06:30AM  
Jan-06-20 06:55AM  
Dec-30-19 06:55AM  
Dec-16-19 02:02PM  
Nov-26-19 07:30AM  
Nov-23-19 01:08AM  
Nov-22-19 08:26AM  
Nov-12-19 07:00AM  
Nov-06-19 07:05PM  
Nov-04-19 10:37AM  
TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; and TX-00THR and TX-0008HR, which are transdermal patch product candidates. The company's clinical development product is TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription prenatal vitamin and hormone therapy drug products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. is headquartered in Boca Raton, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Collins Cooper C.DirectorJun 09Buy1.4547,50068,875140,000Jun 10 04:25 PM
Finizio Robert GCEOJun 09Buy1.4446,00066,36018,401,964Jun 10 04:06 PM
Collins Cooper C.DirectorJun 08Buy1.4526,50038,42592,500Jun 10 04:25 PM
Finizio Robert GCEOJun 05Buy1.1530,00034,60018,355,964Jun 08 04:07 PM
Thompson Tommy GDirectorJun 04Buy1.138,7009,831699,600Jun 08 04:12 PM
BISARO PAULDirectorJun 04Buy1.1450,00057,00050,000Jun 08 04:10 PM